We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,215

US pharma companies under increasing legislative pressure, key EU SPC decision and much more in July’s life sciences IP round-up
  • IAM
  • USA
  • August 9 2018

In this month’s round-up of patent news from the life sciences, we report on the latest blow to the St Regis Mohawks’ attempt shield their Restasis


Senators Urge FDA to Get Tough on Flavored Vaping Products
  • Keller and Heckman LLP
  • USA
  • July 26 2018

Fourteen senators, including Senate Minority Whip Dick Durbin (D-IL), have sent a letter to FDA criticizing the agency for what it characterizes as


The Latest: FTC to Look Closely at Competition between Biologics and Biosimilars and Patent Protection Strategies of Branded Manufacturers
  • McDermott Will & Emery
  • USA
  • July 24 2018

On July 18, 2018, US Food and Drug Administration (FDA) Commissioner Scott Gottlieb delivered a speech at The Brookings Institution in Washington, DC


FDA’s New Biosimilar Action Plan Represents the Next Step for Improving Drug Competition
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 19 2018

On July 18, 2018, after months of alluding to the various aspects of an upcoming “Biosimilar Action Plan” as another prong within FDA’s broader Drug


FTC Says Hatch-Waxman Suits Not Immune from Antitrust Scrutiny
  • Vinson & Elkins LLP
  • USA
  • June 26 2018

The Federal Trade Commission (“FTC”) has sought permission to file an amicus brief in a pharmaceutical patent case, urging a district court to reject


Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • June 26 2018

The response from lawmakers on Capitol Hill to the White House plan to reorganize the federal government


FDA Strives to Adapt Regulatory Approach to Rapidly Evolving Digital Health Space
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • June 19 2018

Just two months after taking office, in July 2017, Food and Drug Administration (FDA) Commissioner Scott Gottlieb announced the agency’s Digital


FTC and House Start Working Together to Address CPSC-related Connected Technology Issues - Stakeholders Should Prepare for Future Government-Wide Cooperation
  • Venable LLP
  • USA
  • June 19 2018

Robust conversations about IoT, smart technology, and product safety continue across the federal government. On May 16, 2018, the Consumer Product


The Internet of Things Medical Devices Liability (Part 1)
  • Seyfarth Shaw LLP
  • USA
  • June 15 2018

We all remember the video from a few years ago in which (benevolent) hackers remotely seized control of an SUV, initially playing with the climate


Internet of Things Webinar Recording: Medical Devices
  • Hogan Lovells
  • USA
  • June 14 2018

In the third instalment of the 2018 Internet of Things Webinar (IoT) Series, Yarmela Pavlovic, Paul Otto, Elisabethann Wright, and Fabien Roy hosted